Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
[kallmann syndrome]
Insulin
-like
factor
3
(
INSL
3
)
is
a
testicular
hormone
secreted
during
fetal
life
,
the
neonatal
period
,
and
after
puberty
.
To
measure
INSL
3
levels
in
a
large
series
of
men
with
congenital
hypogonadotropic
hypogonadism
(
CHH
)
/
Kallmann
syndrome
(
KS
)
,
in
order
to
assess
its
diagnostic
value
and
to
investigate
its
regulation
.
We
studied
281
CHH
/
KS
patients
(
91
untreated
,
96
receiving
T
,
and
94
receiving
combined
gonadotropin
therapy
[
human
chorionic
gonadotropin
,
hCG
,
and
FSH
]
)
and
72
age-matched
healthy
men
.
Serum
INSL
3
was
immunoassayed
with
a
validated
RIA
.
Mean
(
±
SD
)
INSL
3
levels
(
pg
/
mL
)
were
659
±
279
in
controls
and
lower
(
60
±
43
;
P
<
.
001
)
in
untreated
CHH
/
KS
patients
,
with
no
overlap
between
the
two
groups
,
when
the
threshold
of
250
pg
/
mL
was
used
.
Basal
INSL
3
levels
were
lower
in
both
untreated
CHH
/
KS
men
with
cryptorchidism
than
in
those
with
intrascrotal
testes
and
in
patients
with
testicular
volumes
below
4
mL
.
Significant
positive
correlations
between
INSL
3
and
both
serum
total
T
and
LH
levels
were
observed
in
untreated
CHH
/
KS
.
Mean
INSL
3
levels
remained
low
in
T
-
treated
CHH
/
KS
patients
and
were
significantly
higher
in
men
receiving
combined
hCG-FSH
therapy
(
P
<
.
001
)
,
but
the
increase
was
lower
cryptorchid
patients
.
FSH-hCG
combination
therapy
or
hCG
monotherapy
,
contrary
to
T
and
FSH
monotherapies
,
significantly
increased
INSL
3
levels
in
CHH
/
KS
.
INSL
3
is
as
sensitive
a
marker
as
T
for
the
evaluation
of
altered
Leydig
cell
function
in
CHH
/
KS
patients
.
INSL
3
levels
correlate
with
LH
levels
in
CHH
/
KS
men
showing
,
together
with
the
rise
in
INSL
3
levels
during
hCG
therapy
,
that
INSL
3
secretion
seems
not
constitutively
secreted
during
adulthood
but
is
dependence
on
pituitary
LH
.
Diseases
Validation
Diseases presenting
"insulin-like factor"
symptom
kallmann syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom